THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Xichun Yu to Humans

This is a "connection" page, showing publications Xichun Yu has written about Humans.
Connection Strength

0.420
  1. GnRH receptor-activating autoantibodies in polycystic ovary syndrome: identification of functional epitopes and development of epitope mimetic inhibitors. Endocrine. 2022 Mar; 75(3):959-963.
    View in: PubMed
    Score: 0.045
  2. Implications of Antimuscarinic Autoantibodies in Postural Tachycardia Syndrome. J Cardiovasc Transl Res. 2022 04; 15(2):438-440.
    View in: PubMed
    Score: 0.044
  3. Increased testosterone and proinflammatory cytokines in patients with polycystic ovary syndrome correlate with elevated GnRH receptor autoantibody activity assessed by a fluorescence resonance energy transfer-based bioassay. Endocrine. 2021 10; 74(1):163-171.
    View in: PubMed
    Score: 0.043
  4. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome. J Am Heart Assoc. 2018 04 04; 7(8).
    View in: PubMed
    Score: 0.035
  5. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism. J Clin Endocrinol Metab. 2014 May; 99(5):1790-7.
    View in: PubMed
    Score: 0.026
  6. Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. J Biol Chem. 2013 Oct 18; 288(42):30734-30741.
    View in: PubMed
    Score: 0.025
  7. Emerging role of JNK in insulin resistance. Curr Diabetes Rev. 2013 Sep; 9(5):422-8.
    View in: PubMed
    Score: 0.025
  8. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012 Feb; 59(2):402-8.
    View in: PubMed
    Score: 0.023
  9. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens. 2012 Jan-Feb; 6(1):40-7.
    View in: PubMed
    Score: 0.022
  10. Opposing cardiac effects of autoantibody activation of ß-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol. 2011 May 05; 148(3):331-6.
    View in: PubMed
    Score: 0.020
  11. Proteasome inhibition during myocardial infarction. Cardiovasc Res. 2010 Jan 15; 85(2):312-20.
    View in: PubMed
    Score: 0.019
  12. Targeting proteasomes for cardioprotection. Curr Opin Pharmacol. 2009 Apr; 9(2):167-72.
    View in: PubMed
    Score: 0.018
  13. Is pseudo-Cushing's syndrome in a critically ill patient "pseudo"? Hypothesis and supportive case report. Endocr Pract. 2007 Mar-Apr; 13(2):153-8.
    View in: PubMed
    Score: 0.016
  14. Renin-dependent hypertension caused by nonfocal stenotic aberrant renal arteries: proof of a new syndrome. Hypertension. 2005 Aug; 46(2):380-5.
    View in: PubMed
    Score: 0.014
  15. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction. Hypertension. 2015 Oct; 66(4):830-5.
    View in: PubMed
    Score: 0.007
  16. Activating autoantibodies to the ß1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism. Endocrine. 2015 Jun; 49(2):457-63.
    View in: PubMed
    Score: 0.007
  17. Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism. J Am Soc Hypertens. 2015 Jan; 9(1):15-20.
    View in: PubMed
    Score: 0.007
  18. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014 Feb 26; 3(1):e000755.
    View in: PubMed
    Score: 0.007
  19. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J Am Coll Cardiol. 2009 Sep 29; 54(14):1309-16.
    View in: PubMed
    Score: 0.005
  20. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity. 2008 Sep; 41(6):442-53.
    View in: PubMed
    Score: 0.004
  21. Autoimmune hypertensive syndrome. Hypertension. 2007 Nov; 50(5):829-34.
    View in: PubMed
    Score: 0.004
  22. Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension. 2002 Apr; 39(4):935-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES